These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5035273)

  • 21. 3-Chromanamine hydrochlorides with central stimulant activity.
    Lockhart IM; Foard SA
    J Med Chem; 1972 Aug; 15(8):863-5. PubMed ID: 5044309
    [No Abstract]   [Full Text] [Related]  

  • 22. Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
    Atkinson ER; McRitchie DD; Shoer LF; Harris LS; Archer S; Aceto MD; Pearl J; Luduena FP
    J Med Chem; 1977 Dec; 20(12):1612-7. PubMed ID: 592326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships in cinnamamides. 1. Synthesis and pharmacological evaluation of some (E)- and (Z)-N-alkyl-alpha,beta-dimethylcinnamamides.
    Balsamo A; Barili PL; Crotti P; Macchia D; Macchia F; Pecchia A; Cuttica A; Passerini N
    J Med Chem; 1975 Aug; 18(8):842-6. PubMed ID: 1159703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans.
    Kaiser C; Fowler PJ; Tedeschi DH; Lester BM; Garvey E; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):57-62. PubMed ID: 4808470
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of some N-carboxylic acid derivatives of 3-phenoxypyrrolidines, 4-phenoxypiperidines, and 3-phenoxynortropanes with muscle relaxant and anticonvulsant activities.
    Boswell RF; Helsley GC; Duncan RL; Funderburk WH; Johnson DN
    J Med Chem; 1974 Sep; 17(9):1000-8. PubMed ID: 4528755
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the central and peripheral component with respect to the genesis of reserpine ptosis].
    Schmidt G; Kusel HJ; Dal Ri H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):59. PubMed ID: 4231872
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacological profile of diphenylhydantoin in mice.
    Poncelet M; Hakkou F; Simon P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):373-8. PubMed ID: 6541357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agents acting on the central nervous system. 14. 1-(p-Alkanoylphenoxy)-3-(N 4 -arylpiperazinyl)propan-2-ols. A new class of antidepressants.
    Rastogi SN; Anand N; Prasad CR
    J Med Chem; 1972 Mar; 15(3):286-91. PubMed ID: 5059212
    [No Abstract]   [Full Text] [Related]  

  • 29. Retention of configuration in photolytic decarboxylation of peresters to form chiral acetals and ethers.
    Spantulescu MD; Boudreau MA; Vederas JC
    Org Lett; 2009 Feb; 11(3):645-8. PubMed ID: 19113895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological studies on the central action of novel benzylidene-imidazothiazolone derivatives.
    Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Kieć-Kononowicz K; Zejc A
    Pol J Pharmacol Pharm; 1989; 41(4):377-83. PubMed ID: 2576811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound].
    Hoffmann I; Kuch H; Schmitt K; Seidl G
    Arzneimittelforschung; 1970 Jul; 20(7):975. PubMed ID: 5536073
    [No Abstract]   [Full Text] [Related]  

  • 32. Partly reduced biphenyls as cetral nervous system agents. 3. Cis- and trans-4-aryl-4-methoxycyclohexylamines.
    Lednicer D; Emmert DE; Lahti R; Rudzik AD
    J Med Chem; 1973 Nov; 16(11):1251-6. PubMed ID: 4747966
    [No Abstract]   [Full Text] [Related]  

  • 33. 1-Polyfluoroalkylbenzodiazepines; 1.
    Steinman M; Topliss JG; Alekel R; Wong YS; York EE
    J Med Chem; 1973 Dec; 16(12):1354-60. PubMed ID: 4765861
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and central nervous system effects of 8.9-dihydro(1)benzazepino(3,2.1-ak)(1,4)benzodiazepin-1(2H)-ones and (1) binzazepino(3,2,1-jk)(1,4)benzodiazepin-1(2H)-ones.
    Toscano L; Seghetti E; Fioriello G
    J Med Chem; 1975 Oct; 18(10):976-81. PubMed ID: 1159692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Substituted-3-aminoalkoxy-4,5-cycloalkylpyrazoles with central nervous system depressant activity.
    Barbaz BS; Chernov HI; Finch N; Gschwend HW; Hamdan A
    J Med Chem; 1972 Oct; 15(10):1027-9. PubMed ID: 5069769
    [No Abstract]   [Full Text] [Related]  

  • 36. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 37. Alkaloid studies. 7. Reactions of 18-hydroxymethyleneyohimban-17-one and the preparation of yohimbano(17,18-c and 18,17-d)pyrazoles.
    Albright JD; Conroy NH; Goldman L; Osterberg AC
    J Med Chem; 1971 Jul; 14(17):571-4. PubMed ID: 5164445
    [No Abstract]   [Full Text] [Related]  

  • 38. Analgesics. 1. Selected 5-substituted 5-propionoxybarbituric acids.
    Vida JA; Samour CM; O'Dea MH; Wang TS; Wilber WR
    J Med Chem; 1974 Jul; 17(7):732-6. PubMed ID: 4836404
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.
    Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R
    J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.